RxDoctor Payments Data
★ My doctorsLook up a doctor →

Douglas Jeffery

Neurology · Mooresville, NCNPI 1043296130

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $385,780 of the $486,031 with a category attached, or 79.4%. It is spread thinly across 42 manufacturers, the largest accounting for just 23.5%. Reporting peaked in 2019 at $187,148 and has fallen 99.9% since, to $125 in 2023. Among neurology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$486,031in general payments, 2019–2025

Across 777 payments — averaging $625.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$114K
  • Bristol Myers Squibb$111K
  • Genentech USA, Inc.$79K
  • Sanofi$77K
  • Biogen$58K
  • Novartis$19K
  • plus $27K from 36 others
$28,309in research payments, 2019–2025

Across 5 payments — averaging $5661.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$19K
  • Novartis$9K
  • E.r. Squibb & Sons, L.L.C.$77

What the payments were for

  • Consulting fees$61,51413%
  • Speaking & faculty fees$385,78079%
  • Travel & lodging$25,5775%
  • Food & beverage$12,8853%
  • Education$2750%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.76$114,055
Bristol Myers Squibb106$110,995
Genentech USA, Inc.123$79,145
Sanofi135$77,429
Biogen93$57,673
Novartis87$19,445
Johnson & Johnson31$8,988
AstraZeneca18$7,369
EMD Serono, Inc.20$5,441
Genentech, Inc.2$2,448
TG Therapeutics, Inc.3$1,490
SK Life Science, Inc.13$194
Amgen(2 entities)7$143
Sanofi-aventis U.S. LLC3$132
Supernus Pharmaceuticals, Inc.5$93
Mallinckrodt Enterprises LLC5$80
Mallinckrodt Hospital Products Inc.4$74
Amneal Pharmaceuticals LLC3$71
ANI Pharmaceuticals, Inc.3$68
Arbor Pharmaceuticals, Inc.3$63
Pfizer3$52
Acorda Therapeutics, Inc2$49
Banner Life Sciences, LLC3$49
AbbVie(2 entities)3$48
Eisai Inc.2$48
Avanir Pharmaceuticals, Inc.3$46
GE HealthCare2$35
Upsher-smith Laboratories LLC2$33
Grifols USA, LLC2$32
Sunovion Pharmaceuticals Inc.2$32
Biohaven Pharmaceutical Holding Company Ltd.2$31
UCB, Inc.1$22
Biohaven Pharmaceuticals, Inc.1$20
Neurocrine Biosciences, Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19
Jazz Pharmaceuticals Inc.1$17
Greenwich Biosciences, Inc.1$16
Biodelivery Sciences International, Inc.1$15
Philips North America LLC1$15
Akcea Therapeutics, Inc.1$12
Acadia Pharmaceuticals Inc1$12
Advanced Respiratory, Inc1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$486,031 in reported general payments places this provider in the 95th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina →

Other neurology in Mooresville

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →